Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
about
Safety issues associated with using medication to treat overactive bladder.Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection.Quo Vadis Botulinum Toxin: Normative Constraints and Quality of Life for Patients With Idiopathic OAB?Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?
P2860
Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Urinary retention in female OA ...... ection: who is really at risk?
@ast
Urinary retention in female OA ...... ection: who is really at risk?
@en
type
label
Urinary retention in female OA ...... ection: who is really at risk?
@ast
Urinary retention in female OA ...... ection: who is really at risk?
@en
prefLabel
Urinary retention in female OA ...... ection: who is really at risk?
@ast
Urinary retention in female OA ...... ection: who is really at risk?
@en
P2093
P2860
P50
P1476
Urinary retention in female OA ...... ection: who is really at risk?
@en
P2093
Ewa Markut-Miotla
Katarzyna Skorupska
Rufus Cartwright
P2860
P2888
P304
P356
10.1007/S00192-016-3212-4
P577
2016-11-26T00:00:00Z
P6179
1023647287